[(T)BUC(N(I)PR)2]AL(ME)(C6F5)
Compound with spectra: 1 NMR
![[(T)BUC(N(I)PR)2]AL(ME)(C6F5)](/api/compound/39iWCRlaYUt.png?ph=true&h=300&w=458 "[(T)BUC(N(I)PR)2]AL(ME)(C6F5)")
| SpectraBase Compound ID | 39iWCRlaYUt |
|---|---|
| InChI | InChI=1S/C11H23N2.C6F5.CH3.Al/c1-8(2)12-10(11(5,6)7)13-9(3)4;7-2-1-3(8)5(10)6(11)4(2)9;;/h8-9H,1-7H3;;1H3;/q-1;;;+1 |
| InChIKey | XMKXOGDSMCTJFZ-UHFFFAOYSA-N |
| Mol Weight | 392.39 g/mol |
| Molecular Formula | C18H26AlF5N2 |
| Exact Mass | 392.183153 g/mol |
| Parent InChIKey | XIYAXOZTLPKWDE-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
2-tert-Butyl-N-cyclooctyl-5-[(4-ethoxyphenyl)methyl]-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide
3,3-dimethyl-11-(3-methyl-2-thienyl)-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
(3R,4S,5R,7S,9R)-3-ACETOXY-9-(3-METHYL-2-BUTENOYLOXY)-SOLAVETIVONE
ENT-5-ALPHA,3,15-DIOXODOLABR-1,4(18)-DIENE-2,16-DIOL
3-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-5-phenyl-1-(4-(6-thioxo-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)phenyl)-1H-pyrrol-2(3H)-one
6-acetyl-7,7a-dihydro-1,7a-dimethyl-7-imino-2-phenyl-1H-pyrazolo[4,3-c]pyridazin-3(2H)-one
ENDO-1,2,3,4-TETRAHYDRO-5,6,7,8,9,N'-HEXAMETHYL-1,4-IMINONAPHTHALINE-2,3-DICARBOXIMIDE
[1,3'-Bi-1H-indene]-1',3,5',6(2H,3aH,4'H)-tetrone, 3'a,4,5,6',7,7',7a,7'a-octahydro-3a,7'a-dimethyl-
Testosterone decanoate TMS
3-(4-(3-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-2-oxo-5-phenyl-2,3-dihydropyrrol-1-yl)phenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6(5H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Structures of Cationic Aluminum and Gallium Amidinate Complexes | Journal of the American Chemical Society | 1999 |